## Note
nid: 1488854891621
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::!FLAG_THESE_CARDS::Potential_duplicates, #AK_Step1_v11::#B&B::11_Hematology::01_Hemostasis::06_Antiplatelet_Drugs, #AK_Step1_v11::#FirstAid::11_Musculoskeletal_Skin_Connective_Tissue::04_Pharm::01_Arachidonic_Acid_Pathway, #AK_Step1_v11::#FirstAid::11_Musculoskeletal_Skin_Connective_Tissue::04_Pharm::01_Arachidonic_Acid_Pathway::NSAIDs_Sketch, #AK_Step1_v11::#OME_banner::Basic_Science::13_Hematology_Oncology::11_Hemostasis, #AK_Step1_v11::#Physeo::09_Pharm::09_Musculoskeletal::04_NSAIDs, #AK_Step1_v11::#Pixorize::03_Pharm::12_MSK::NSAIDs, #AK_Step1_v11::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::01_NSAIDs, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::3-HighYield-temporary, #AK_Step1_v11::^Systems::Musculoskeletal::Pharmacology
markdown: false

### Text
What is the <u>precursor</u> molecule to <b>prostanoids</b> and
<b>leukotrienes</b>?
<div>
  {{c1::Arachidonic acid}}
</div>

### Extra
<img src="paste-780623190950431.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-147106924855299.jpg"><img src=
"paste-634817641185283.jpg"><img src=
"paste-638021686788099.jpg"><img src=
"paste-232039903133699.jpg"><img src=
"paste-644528562241539.jpg"><img src="paste-224652559384579.jpg">

### Sketchy
<img src="paste-577441173078017.jpg"> <img src=
"paste-af3fac2cfd689d0be10bb96ebcb5bb3df0c0c332.png"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-blood-inflammation/videos/medical-pharmacology-blood-and-inflammation-anti-inflammatory-nsaids?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch NSAIDs</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/heme-onc/hemostasis/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_6.png"></a>
</div>

### Additional Resources


### One by one

